Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis

Neuropathology and Applied Neurobiology

Volumn 40, Issue 2, 2014, Pages 191-204

  Crevecoeur J ^a   Kaminski, R M ^c   Rogister, B ^a,b   Foerch, P ^c   Vandenplas, C ^c   Neveux, M ^c   Mazzuferi, M ^c   Kroonen, J ^a   Poulet, C ^a   Martin, D ^b   Sadzot, B ^b   Rikir, E ^b   Klitgaard, H ^c   Moonen, G ^a,b   Deprez, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UCB PHARMA   (Belgium)

Author keywords

Human; Mesial temporal sclerosis; Sprouting mossy fibres; SV2; Temporal lobe epilepsy

Indexed keywords

DYNORPHIN; PROTEIN; SYNAPTIC VESICLE PROTEIN 2; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; ZINC TRANSPORTER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DENTATE GYRUS; DNA DETERMINATION; FEMALE; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOSSY FIBER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SYNAPSE; TEMPORAL LOBE EPILEPSY;

HUMAN; MESIAL TEMPORAL SCLEROSIS; SPROUTING MOSSY FIBRES; SV2; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; CHILD; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; SCLEROSIS; SYNAPSES; YOUNG ADULT;

EID: 84892657640     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12054     Document Type: Article

References (46)

1. Chang W-P, Südhof TC. SV2 renders primed synaptic vesicles competent for Ca2+-induced exocytosis. J Neurosci 2009; 29: 883-897
2. Janz R, Goda Y, Geppert M, Missler M, Südhof TC. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 1999; 24: 1003-1016
3. Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 1994; 14: 5223-5235
4. Hayashi M, Yamamoto A, Yatsushiro S, Yamada H, Futai M, Yamaguchi A, Moriyama Y. Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes. J Neurochem 1998; 71: 356-365
5. Dardou D, Dassesse D, Cuvelier L, Deprez T, De Ryck M, Schiffmann SN. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Brain Res 2011; 1367: 130-145
6. Janz R, Südhof TC. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience 1999; 94: 1279-1290
7. Gronborg M, Pavlos NJ, Brunk I, Chua JJ, Munster-Wandowski A, Riedel D, Ahnert-Hilger G, Urlaub H, Jahn R. Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J Neurosci 2010; 30: 2-12
8. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006; 312: 592-596
9. Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 2006; 536: 102-108
10. van Vliet EA, Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007; 130: 521-534
11. Klitgaard H, Verdu P. Levetiracetam: the first SV2A ligand for the treatment of epilepsy. Expert Opin Drug Discov 2007; 2: 1537-1545
12. Matagne A, Margineanu D-G, Kenda B, Michel P, Klitgaard H. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol 2008; 154: 1662-1671
13. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A 1999; 96: 15268-15273
14. Kaminski RM, Matagne A, Leclercq K, Gillard M, Michel P, Kenda B, Talaga P, Klitgaard H. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 2008; 54: 715-720
15. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, Wadman WJ. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 2006; 26: 11083-11110
16. De Smedt T, Raedt R, Vonck K, Boon P. Levetiracetam: the profile of a novel anticonvulsant drug - part I: preclinical data. CNS Drug Rev 2007; 13: 43-56
17. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004; 101: 9861-9866
18. Lynch JM, Tate SK, Kinirons P, Weale ME, Cavalleri GL, Depondt C, Murphy K, O'Rourke D, Doherty CP, Shianna KV, Wood NW, Sander JW, Delanty N, Goldstein DB, Sisodiya SM. No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. Epilepsy Res 2009; 83: 44-51
19. van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia 2009; 50: 422-433
20. Wang MM, Janz R, Belizaire R, Frishman LJ, Sherry DM. Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina. J Comp Neurol 2003; 460: 106-122
21. Wan QF, Zhou ZY, Thakur P, Vila A, Sherry DM, Janz R, Heidelberger R. SV2 acts via presynaptic calcium to regulate neurotransmitter release. Neuron 2010; 66: 884-895
22. Iezzi M, Theander S, Janz R, Loze C, Wollheim CB. SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment. J Cell Sci 2005; 118: 5647-5660
23. Yang W, Maqsodi B, Ma Y, Bui S, Crawford KL, McMaster GK, Witney F, Luo Y. Direct quantification of gene expression in homogenates of formalin-fixed, paraffin-embedded tissues. Biotechniques 2006; 40: 481-486
24. Tsongalis GJ. Branched DNA technology in molecular diagnostics. Am J Clin Pathol 2006; 126: 448-453
25. Knudsen BS, Allen AN, McLerran DF, Vessella RL, Karademos J, Davies JE, Maqsodi B, McMaster GK, Kristal AR. Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues. J Mol Diagn 2008; 10: 169-176
26. Lynoë N, Sandlund M, Dahlgvist G, Jacobsson L. Declaration of Helsinki. Br Med J 1991; 302: 1194
27. Blümcke I, Pauli E, Clusmann H, Schramm J, Becker A, Elger C, Merschhemke M, Meencke H-J, Lehmann T, von Deimling A, Scheiwe C, Zentner J, Volk B, Romstöck J, Stefan H, Hildebrandt M. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol (Berl) 2007; 113: 235-244
28. Miyauchi N, Saito A, Karasawa T, Harita Y, Suzuki K, Koike H, Han GD, Shimizu F, Kawachi H. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli. J Am Soc Nephrol 2006; 17: 2748-2759
29. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23: 291-299
30. Danscher G, Stoltenberg M, Bruhn M, Søndergaard C, Jensen D. Immersion autometallography: histochemical in situ capturing of zinc ions in catalytic zinc-sulfur nanocrystals. J Histochem Cytochem 2004; 52: 1619-1625
31. Károly N, Mihály A, Dobó E. Comparative immunohistochemistry of synaptic markers in the rodent hippocampus in pilocarpine epilepsy. Acta Histochem 2011; 113: 656-662
32. Proper EA, Oestreicher AB, Jansen GH, Veelen CW, van Rijen PC, Gispen WH, de Graan PN. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2000; 123 (Pt 1): 19-30
33. Sloviter R. A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res Bull 1982; 8: 771-774
34. R Core Team. R: a language and environment for statistical computing. 2012 [cited; R Foundation for Statistical Computing]. Available at: http://www.R-project.org/ (last accessed 11 January 2013)
35. de Groot M, Toering ST, Boer K, Spliet WGM, Heimans JJ, Aronica E, Reijneveld JC. Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex. Neuro-oncol 2010; 12: 265-273
36. Thom M, Sisodiya S, Najm I. Neuropathology of epilepsy. In Greenfield's Neuropathology, 8th edn. Eds S Love, DN Louis, DW Ellison. London: Hodder Arnold, 2008; 833-887
37. Amaral D, Lavenex P. Hippocampal neuroanatomy. In The Hippocampus Book. Eds P Andersen, R Morris, D Amaral, T Bliss, J O'Keefe. New York: Oxford University Press, 2007; 37-114
38. Palmiter RD, Cole TB, Quaife CJ, Findley SD. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A 1996; 93: 14934-14939
39. Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WGM, van Rijen PC, Jansen FE, Gorter JA, Reijneveld JC, Aronica E. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia 2009; 50: 1409-1418
40. de Groot M, Aronica E, Heimans JJ, Reijneveld JC. Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma. Neurology 2011; 77: 532-539
41. Wan QF, Vila A, Zhou ZY, Heidelberger R. Synaptic vesicle dynamics in mouse rod bipolar cells. Vis Neurosci 2008; 25: 523-533
42. Babb TL, Kupfer WR, Pretorius JK, Crandall PH, Levesque MF. Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience 1991; 42: 351-363
43. Amano S, Ikeda M, Uemura S, Fukuoka J, Tsuji A, Sasahara M, Hayase Y, Hazama F. Mossy fiber sprouting in the dentate gyrus in a newly developed epileptic mutant, Ihara epileptic rat. Brain Res 1999; 834: 214-218
44. Laurberg S, Zimmer J. Lesion-induced sprouting of hippocampal mossy fiber collaterals to the fascia dentata in developing and adult rats. J Comp Neurol 1981; 200: 433-459
45. Doering P, Danscher G, Larsen A, Bruhn M, Søndergaard C, Stoltenberg M. Changes in the vesicular zinc pattern following traumatic brain injury. Neuroscience 2007; 150: 93-103
46. Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Lüders H, Pedley TA, (ILAE) CoNotILAE. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001; 42: 282-286